Axsome Therapeutics(AXSM)
$141.69-2.68 (-1.86%)
AXSM
Axsome Therapeutics financials statements
$141.69
At close:-2.68 (-1.86%)
Want to see AXSM full AI Analyst Report?
Axsome Therapeutics (AXSM) Income Statement
2,421 Followers
Axsome Therapeutics Income Statement
Last quarter (Q3 2026), Axsome Therapeutics's total revenue was $259.69M, an increase of 51.87% from the same quarter last year. In Q3, Axsome Therapeutics's net income was $-12.88M. See Axsome Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 638.50M | $ 385.69M | $ 270.60M | $ 50.04M | $ 0.00 | |
| $ 591.02M | $ 352.39M | $ 244.53M | $ 44.84M | $ 0.00 | |
| $ 760.25M | $ 632.95M | $ 476.36M | $ 224.64M | $ 124.71M | |
| Depreciation and Amortization | $ 9.06M | $ 7.96M | $ 6.83M | $ 4.40M | $ 76.00K |
| $ -168.08M | $ -272.60M | $ -224.99M | $ -175.40M | $ -124.63M | |
| $ -169.24M | $ -280.56M | $ -231.82M | $ -179.80M | $ -124.71M | |
| $ -14.47M | $ -6.57M | $ -6.45M | $ -7.33M | $ -5.70M | |
| $ -183.70M | $ -287.13M | $ -238.28M | $ -187.13M | $ -130.40M | |
| $ -183.17M | $ -287.22M | $ -239.24M | $ -187.13M | $ -130.40M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.68 | $ -5.99 | $ -5.27 | $ -4.60 | $ -3.47 |
| Diluted EPS | $ -3.68 | $ -5.99 | $ -5.27 | $ -4.60 | $ -3.47 |
| Weighted Average Shares Outstanding | 49.75M | 47.91M | 45.43M | 40.66M | 37.62M |
| Weighted Average Shares Outstanding (Diluted) | 49.75M | 47.91M | 45.43M | 40.66M | 37.62M |
Currency in USD
